Skip to main content

Advertisement

SpringerLink
Log in

Primary Esophagogastric Neuroendocrine Carcinoma: a Retrospective Study from the Nottingham Upper Gastrointestinal Cancer Center

  • Mgmt. of Complex Cases in GI Oncology
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Niederle MB, Hackl M, Kaserer K, Niederle B. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer. 2010;17(4):909–18. https://doi.org/10.1677/ERC-10-0152.

    Article  PubMed  Google Scholar 

  2. Godwin JD 2nd. Carcinoid tumors. An analysis of 2,837 cases. Cancer. 1975;36(2):560–9. https://doi.org/10.1002/1097-0142(197508)36:2<560::AID-CNCR2820360235>3.0.CO;2-4.

    Article  PubMed  Google Scholar 

  3. Gastrointestinal Pathology Study Group of Korean Society of P, et al. Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter study. Cancer Res Treat. 2012;44(3):157–65.

    Article  Google Scholar 

  4. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79(4):813–29.

    Article  CAS  PubMed  Google Scholar 

  5. Lee CG, et al. The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea. BMC Cancer. 2014;14(1):569. https://doi.org/10.1186/1471-2407-14-569.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Estrozi B, Bacchi CE. Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases. Clinics (Sao Paulo). 2011;66(10):1671–5.

    Google Scholar 

  7. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934–59. https://doi.org/10.1002/cncr.11105.

    Article  PubMed  Google Scholar 

  8. Wong YN, et al. The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004. BMC Cancer. 2009;9(1):209. https://doi.org/10.1186/1471-2407-9-209.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Yamaguchi T, Machida N, Morizane C, Kasuga A, Takahashi H, Sudo K, et al. Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system. Cancer Sci. 2014;105(9):1176–81. https://doi.org/10.1111/cas.12473.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hoang MP, Hobbs CM, Sobin LH, Albores-Saavedra J. Carcinoid tumor of the esophagus: a clinicopathologic study of four cases. Am J Surg Pathol. 2002;26(4):517–22. https://doi.org/10.1097/00000478-200204000-00016.

    Article  PubMed  Google Scholar 

  11. Huang Q, Wu H, Nie L, Shi J, Lebenthal A, Chen J, et al. Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. Am J Surg Pathol. 2013;37(4):467–83. https://doi.org/10.1097/PAS.0b013e31826d2639.

    Article  PubMed  Google Scholar 

  12. Kloppel G. Tumour biology and histopathology of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab. 2007;21(1):15–31. https://doi.org/10.1016/j.beem.2007.01.004.

    Article  PubMed  Google Scholar 

  13. Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9(1):61–72. https://doi.org/10.1016/S1470-2045(07)70410-2.

    Article  CAS  PubMed  Google Scholar 

  14. International Classification of Diseases for Oncology, C.F. Bosman FT, Hruban RH, Theise ND., Editor. 2010, International Agency for Research on Cancer: Lyon.

  15. TNM Classification of Malignant Tumours, in UICC International Union Against Cancer, M.G. Leslie Sobin, Christian Wittekind, Editor. 2010, Blackwell Publishing p 66-77.

  16. Peng C, Shen S, Zhang X, Zou X. Limited stage small cell carcinoma of the gastrointestinal tract: a clinicopathologic and prognostic analysis of 27 cases. Rare Tumors. 2013;5(1):e6. https://doi.org/10.4081/rt.2013.e6.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Yun JP, Zhang MF, Hou JH, Tian QH, Fu J, Liang XM, et al. Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases. BMC Cancer. 2007;7(1):38. https://doi.org/10.1186/1471-2407-7-38.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Liang J, Liu S. Clinicopathological features of the primary gastric neuroendocrine neoplasms. Zhonghua Zhong Liu Za Zhi. 2014;36(7):522–8.

    PubMed  Google Scholar 

  19. Brenner B, Shah MA, Gonen M, Klimstra DS, Shia J, Kelsen DP. Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. Br J Cancer. 2004;90(9):1720–6. https://doi.org/10.1038/sj.bjc.6601758.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Hudson E, Powell J, Mukherjee S, Crosby TDL, Brewster AE, Maughan TS, et al. Small cell oesophageal carcinoma: an institutional experience and review of the literature. Br J Cancer. 2007;96(5):708–11. https://doi.org/10.1038/sj.bjc.6603611.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Li AF, et al. Small cell carcinomas in gastrointestinal tract: immunohistochemical and clinicopathological features. J Clin Pathol. 2010;63(7):620–5. https://doi.org/10.1136/jcp.2010.077024.

    Article  PubMed  Google Scholar 

  22. Wong AT, Shao M, Rineer J, Osborn V, Schwartz D, Schreiber D. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base. Dis Esophagus. 2016; https://doi.org/10.1111/dote.12487.

  23. Brenner B, Tang LH, Klimstra DS, Kelsen DP. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 2004;22(13):2730–9. https://doi.org/10.1200/JCO.2004.09.075.

    Article  PubMed  Google Scholar 

  24. Lv J, Liang J, Wang J, Wang L, He J, Xiao Z, et al. Primary small cell carcinoma of the esophagus. J Thorac Oncol. 2008;3(12):1460–5. https://doi.org/10.1097/JTO.0b013e31818e1247.

    Article  PubMed  Google Scholar 

  25. Kloppel G. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer. 2011;18(Suppl 1):S1–16. https://doi.org/10.1530/ERC-11-0013.

    Article  PubMed  Google Scholar 

  26. Kloppel G, Anlauf M. Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2005;19(4):507–17. https://doi.org/10.1016/j.bpg.2005.02.010.

    Article  PubMed  Google Scholar 

  27. Attar BM, Levendoglu H, Rhee H. Small cell carcinoma of the esophagus. Report of three cases and review of the literature. Dig Dis Sci. 1990;35(1):145–52. https://doi.org/10.1007/BF01537236.

    Article  CAS  PubMed  Google Scholar 

  28. Bennouna J, Bardet E, Deguiral P, Douillard JY. Small cell carcinoma of the esophagus: analysis of 10 cases and review of the published data. Am J Clin Oncol. 2000;23(5):455–9. https://doi.org/10.1097/00000421-200010000-00005.

    Article  CAS  PubMed  Google Scholar 

  29. Ho KJ, Herrera GA, Jones JM, Alexander CB. Small cell carcinoma of the esophagus: evidence for a unified histogenesis. Hum Pathol. 1984;15(5):460–8. https://doi.org/10.1016/S0046-8177(84)80081-7.

    Article  CAS  PubMed  Google Scholar 

  30. Law SY, et al. Small cell carcinoma of the esophagus. Cancer. 1994;73(12):2894–9. https://doi.org/10.1002/1097-0142(19940615)73:12<2894::AID-CNCR2820731204>3.0.CO;2-M.

    Article  CAS  PubMed  Google Scholar 

  31. Chen SB, Yang JS, Yang WP, Weng HR, Li H, Liu DT, et al. Treatment and prognosis of limited disease primary small cell carcinoma of esophagus. Dis Esophagus. 2011;24(2):114–9. https://doi.org/10.1111/j.1442-2050.2010.01112.x.

    Article  PubMed  Google Scholar 

  32. Li S, Cao X, Jiang C, Wang Q. Combined neuroendocrine carcinoma and adenocarcinoma in the stomach: a case report. Oncol Lett. 2014;7(4):953–5. https://doi.org/10.3892/ol.2014.1825.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Takubo K, Nakamura KI, Sawabe M, Arai T, Esaki Y, Miyashita M, et al. Primary undifferentiated small cell carcinoma of the esophagus. Hum Pathol. 1999;30(2):216–21. https://doi.org/10.1016/S0046-8177(99)90279-4.

    Article  CAS  PubMed  Google Scholar 

  34. Lam KY, Law S, Tung PH, Wong J. Esophageal small cell carcinomas: clinicopathologic parameters, p53 overexpression, proliferation marker, and their impact on pathogenesis. Arch Pathol Lab Med. 2000;124(2):228–33. https://doi.org/10.1043/0003-9985(2000)124<0228:ESCC>2.0.CO;2.

    CAS  PubMed  Google Scholar 

  35. MacPherson D. Small cell lung cancer: new insights into origins. Cell Cycle. 2011;10(20):3432. https://doi.org/10.4161/cc.10.20.17664.

    Article  CAS  PubMed  Google Scholar 

  36. Goldstein AS, Huang J. Do neuroendocrine cells come up large in small cell lung cancer? Cell Cycle. 2011;10(21):3627. https://doi.org/10.4161/cc.10.21.17688.

    Article  CAS  PubMed  Google Scholar 

  37. Onuki N, Wistuba II, Travis WD, Virmani AK, Yashima K, Brambilla E, et al. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer. 1999;85(3):600–7. https://doi.org/10.1002/(SICI)1097-0142(19990201)85:3<600::AID-CNCR10>3.0.CO;2-W.

    Article  CAS  PubMed  Google Scholar 

  38. Calbo J, van Montfort E, Proost N, van Drunen E, Beverloo HB, Meuwissen R, et al. A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. Cancer Cell. 2011;19(2):244–56. https://doi.org/10.1016/j.ccr.2010.12.021.

    Article  CAS  PubMed  Google Scholar 

  39. Meder L, König K, Ozretić L, Schultheis AM, Ueckeroth F, Ade CP, et al. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas. Int J Cancer. 2016;138(4):927–38. https://doi.org/10.1002/ijc.29835.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors declare that they did not have any industrial links of affiliations.

Author information

Authors and Affiliations

  1. Department of Oncology, Nottingham University Hospitals, Nottingham, NG5 1PB, UK

    Constantinos Savva, Eleanor James & Srinivasan Madhusudan

  2. Department of Pathology, Nottingham University Hospitals, Nottingham, NG5 1PB, UK

    Philip Kaye & Irshad Soomro

  3. Department of Surgery, Nottingham University Hospitals, Nottingham, NG5 1PB, UK

    Simon L. Parsons

  4. Translational Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, NG5 1PB, UK

    Srinivasan Madhusudan

Authors
  1. Constantinos Savva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip Kaye
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Irshad Soomro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Simon L. Parsons
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eleanor James
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Srinivasan Madhusudan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Srinivasan Madhusudan.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Savva, C., Kaye, P., Soomro, I. et al. Primary Esophagogastric Neuroendocrine Carcinoma: a Retrospective Study from the Nottingham Upper Gastrointestinal Cancer Center. J Gastrointest Canc 49, 85–92 (2018). https://doi.org/10.1007/s12029-017-0039-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-017-0039-2

Search

Navigation